MDM2 and cancer: Patients with high expression of HOXA13 had higher histological grades and higher T/N stages14, A study revealed that HOXA13 plays a cancer-promoting role by directly downregulating DHRS2 and upregulating MDM2 and promotes drug resistance through the p53 pathway33.